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Abstract
High-Z nano materials have been previously shown to increase the amount of 
dose deposition within the tumour due to an increase in secondary electrons.
This study evaluates the effects of high-Z nano materials in combination 
with protons, and the impact of proton energy, nanoparticle material and 
concentration. These effects were studied in silico through Monte Carlo 
simulation and experimentally through a phantom study, with particular 
attention to macroscale changes to the Bragg peak in the presence of 
nanoparticles. Three nanoparticle materials were simulated (gold, silver and 
platinum) at three concentrations (0.01, 0.1 and 6.5 mg ml−1) at two clinical 
proton energies (60 and 226 MeV). Simulations were verified experimentally 
using Gafchromic film measurements of gold nanoparticles suspended in 
water at two available high concentrations (5.5 mg ml−1 and 1.1 mg ml−1). 
A significant change to Bragg peak features was evident, where at 226 MeV and 
6.5 mg ml−1, simulations of gold showed a 4.7 mm longitudinal shift of the 
distal edge and experimentally at 5.5 mg ml−1, a shift of 2.2 mm. Simulations 
showed this effect to be material dependent, where platinum having the highest 
physical density caused the greatest shift with increasing concentration. 
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A dose enhancement of 6%  ±  0.05 and 5%  ±  0.15 (60 MeV and 226 MeV, 
respectively) was evident with gold at 6.5 mg ml−1 to water alone, compared 
to the 21%  ±  0.53 observed experimentally as dose to film with 5.5 mg ml−1 
of gold nanoparticles suspended in water at 226 MeV. The introduction of 
nanoparticles has strong potential to enhance dose in proton therapy, however 
the changes to the Bragg peak distribution that occur with high concentrations 
need to be accounted for to ensure tumour coverage.
Keywords: proton therapy, nanoparticles, range shift
(Some figures may appear in colour only in the online journal)
1. Introduction
Currently there is a growing interest in the use of high-Z nanoparticles (NPs) in radiotherapy, 
due to both a predicted and experimentally observed dose enhancement with photon irradia-
tion (Chithrani et al 2010, Lechtman et al 2013, Taupin et al 2015). If targeted to the tumour, 
high-Z NPs can localise and enhance dose specifically to the tumour and thus giving potential 
to minimise healthy tissue radiation damage. One of the first studies demonstrating this effect 
was carried out using gold NPs in mice where a one-year survival of 86% was found with NPs 
compared to 20% with radiation alone (Hainfeld et al 2004).
Few NP studies have been carried out in proton beams, including a number of Monte 
Carlo simulations. Wälzlein et al (2014) conducted a simulation of a nanosphere of con-
trollable material surrounded by water, with proton dose enhancement up to a factor of 
2 for gold and platinum at 80 MeV. Another Monte Carlo study conducted by Gao and 
Zheng (2014) simulated a single gold NP within a water phantom; they concluded that the 
production of secondary electrons increased with decreasing proton energy, whereas the 
average kinetic energy of secondary electrons stemming from gold NP interaction increased 
with proton energy. Kwon et  al (2015) also simulated a single gold nanoparticle within 
water. Here however they considered the radial dose distribution due to secondary electrons, 
where they found that the effect due to gold nanoparticles extended over several microm-
eters in the longitudinal direction and several nanometers in the radial direction. Lin et al 
(2014) demonstrated a difference in enhancement mechanisms between proton and photon 
NP-interactions through Monte Carlo simulations, where with protons, the highest enhance-
ment was found closer to the NP. A biological model showed that for protons a higher NP 
concentration was needed to achieve the same effect compared to photons for extra-nuclear 
cell-internalised gold NPs (Lin et al 2015).
A number of biological studies support the dose enhancement evident in simulations. Kim 
et al (2012) investigated the use of gold and iron nanoparticles in a mouse model at incident 
proton energy 45 MeV; a one-year survival of 58–100% was found with nanoparticles com-
pared to 11–13% with irradiation alone. Polf et al (2011) investigated nanoparticles of diam-
eter 44 nm located in a tissue equivalent phantom at concentration 1 ng/cell. An increase in the 
effectiveness of tumour cell killing by 15–20% was found at incident proton energy 160 MeV.
As evident from these studies, there is potential for proton dose enhancement from the 
introduction of nanoparticles into tissue; however, the optimum nanoparticle parameters have 
not been determined for proton therapy. To summarise, photon studies have demonstrated that 
the level of enhancement is influenced by the size, concentration, material of nanoparticles 
and beam energy. It has been shown by Chithrani et al (2006) that NP cellular uptake through 
endocytosis is NP size dependent with an optimum size of 50 nm.
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Previous Monte Carlo studies have successfully demonstrated the beneficial effects of 
nanoparticles on the nanoscale. However, these studies have modelled a single nanoparticle 
and therefore do not demonstrate the macro scale effects or bulk effect of clinically relevant 
concentrations of nanoparticles on the Bragg peak (BP) position and shape. Here, we present a 
nano-film model able to simulate nanoparticle concentrations in a non-computationally expen-
sive manner, with controllable material type and concentration. The simulations investigated 
three clinically relevant materials, (Gold (Au), Silver (Ag) and Platinum (Pt)), all of which are 
biocompatible and can therefore be used clinically (Butterworth et al 2008, Porcel et al 2010, 
Jain et  al 2014). Three clinically relevant concentrations were considered (0.01 mg ml−1, 
0.1 mg ml−1 and 6.5 mg ml−1) at two proton energies (60 MeV and 226 MeV). These simula-
tions were then validated through an experiment at the Trento Proton Therapy Center, Italy, 
which had a maximum beam energy of 226 MeV.
2. Materials and methods
2.1. Monte Carlo simulation
The Monte Carlo simulation toolkit Geant4 version 10.0p02 (Agostinelli et al 2003) was used 
to investigate the effects of high-Z nano-materials using incident protons. Using a similar idea 
to that of Allen et al (1999) where they explored the use of thin foils, we were able to create a 
geometry that used nano-films. Nano-films were used to limit the computational time for 1D 
nano-distributions.
Each film had a width and length equal to those of our simulated water phantom, and 
thickness in dimensions of nanometers. Using this setup, we were able to simulate a nano-
particle concentration by modelling the average inter-nanoparticle distance for the concentra-
tion being considered, where this spacing would represent the thickness of water contained 
between subsequent films. The spacing was given by equation (1),
∼r
n
1
1/3
 (1)
where r is the inter-particle spacing and n is the particle density. Calculating nano-film num-
bers in such a manner allowed us to also account for differences in density, where denser 
materials would have fewer nano-films for the same concentration. With this calculation the 
average inter-particle distance was approximated, such that the value was divisible into phan-
tom layers 50 nm thick; this was the selected thickness of the nano-film corresponding to 
the optimum nanoparticle diameter quoted for cellular uptake (Chithrani et  al 2006). The 
inter-nano-film distance varied between 0.45 mm at 6.5 mg ml−1 to 5.15 mm at 0.01 mg ml−1, 
depending on the concentration and physical density of the material.
Films were placed within the BP width, defined as the distance between the 80% proximal 
and 80% distal dose (figure 1). A control was performed without nano-films for comparison. For 
the purposes of this study, two clinically relevant energies were simulated, one at 60 MeV, com-
monly used for ocular tumours (Damato et al 2005), the other at 226 MeV, used predominately 
for deep-seated tumours. The beam sizes had diameters of 7 mm and 2.7 mm for energies of 60 
and 226 MeV respectively, representative of clinical beam sizes. A monoenergetic proton beam 
was used with 8  ×  106 incident protons, to achieve Poisson statistical errors less than 2%.
The main assumption of the nano-film model was that the nanoscale was simulated in the lon-
gitudinal beam direction only. For this assumption to be valid a correction was applied to exclude 
secondary particles which travelled laterally. Using the energy deposited it was then possible to 
calculate the dose to water, allowing depth dose plots to be plotted to investigate BP changes. In 
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order to quote energy deposition to water, energy deposited within the nano-films was excluded. 
This was similarly carried out for the secondary particles recorded within the nano-films.
By using the nano-film model it was possible to investigate many different aspects of 
dose enhancement and energy distribution: (i) BP width (previously defined) was calculated, 
related to changes to the Bragg peak shape. Due to changes in shape, measurements were car-
ried out at two points. The first was between the proximal 80% and distal 80% defined as the 
width of the BP, the other between the proximal 80% and distal 10% demonstrating changes 
that occur towards the end of range. (ii) Longitudinal shift, related to potential changes in 
tumour coverage, defined at the end of range, using the depth where the dose had fallen to 
0 Gy for each material compared to water. For the 226 MeV simulations a dose value was 
obtained every 0.1 mm within this region, whereas for 60 MeV this was at every 0.01 mm. (iii) 
Dose enhancement factor (DEF), related to physical dose and defined as the ratio of the dose 
to water with nano-films compared to the dose to water alone. DEF was quoted within specific 
regions; (a) comparing peak dose values of water  +  nano-films to water alone, (b) consider-
ing the volume up to the peak dose for water  +  nano-films to water alone. These measures 
allowed for any changes in the shape of the BP to be taken into account. (iv) Enhancement range, 
related to BP shape changes and, defined as the distance spanning the beginning of the nano-
film region, where the DEF is 1, and ending at the last point where the DEF is 1, (figure 1(B)). 
This allowed for longitudinal shifts or narrowing of the BP to be quantified. (v) The type of 
secondary particles produced, to investigate the cause of the predicted enhancement.
2.2. Experimental measurements
To validate our findings, measurements were carried out at the Trento Proton Therapy Center, 
Italy, using a 226 MeV beam. A phantom was developed to provide i) dose measurement at 
Figure 1. (A) Nano-film simulation model. Nano-films were contained within the 80% 
to 80% width of the BP within a water phantom. Nano-films had length and width equal 
to that of the water volume and thickness 50 nm. (B) Enhancement range shows the 
distance over which the nano-films enhance the dose (DEF  >  1).
R Ahmad et alPhys. Med. Biol. 61 (2016) 4537
4541
(ii) sufficient spatial resolution of dose measurement at a range of nanoparticle concentrations. 
Gafchromic films were used for our measurements, although some have reported an underesti-
mation within the BP region (Reinhardt et al 2012). This was not an issue as a relative measure-
ment was needed to compare with and without nanoparticles, and so the overall enhancement 
effects along with changes to the BP would still be observed. Therefore, EBT3 (Ashland, USA) 
was used along with a custom made PMMA phantom which could hold Gafchromic film pieces 
at different depths through the phantom along the beam direction (figure 2).
The phantom had external dimensions of 6.1  ×  5  ×  4 cm3 and internal dimensions of 
4.1  ×  3  ×  3 cm3. Dose measurements were obtained at 1 mm intervals. Each slit, for film 
placement, was 0.5 mm thick. Films were marked for orientation and labelled for scanning 
post-irradiation. A concentration of 5.5 and 1.1 mg ml−1 of spherical gold nanoparticles with 
a diameter of 50.7  ±  7.1 nm (nanoComposix, San Diego), suspended in de-ionised water were 
used to assess the effect of concentration on dose. A concentration of 6.5 mg ml−1, equal to 
the highest simulated concentration, was not commercially available, where this concentration 
was simulated as it was representative of in vivo gold nanoparticle uptake. The concentra-
tions of 5.5 and 1.1 mg ml−1 were sufficient as the experiment was used to verify the macro 
scale changes, rather than a direct quantitative comparison. In order to carry out a direct 
compariso n, additional simulations were carried out, for gold, to demonstrate the simulated 
effects with concentrations of 5.5 and 1.1 mg ml−1.
As shown in figure  2 the setup consisted of several blocks of solid water (Gammex, 
Middleton, WI) and an entrance window comprised of PMMA, with a total water equivalent 
thickness (WET) of 29.1 cm, creating a sufficient build-up of dose, allowing the BP width 
to be contained within the phantom. The main compartment of the film phantom had a lat-
eral depth of 4.1 cm filled with solution of either distilled water or de-ionised water  +  gold 
nanoparticles of a known concentration. Whilst carrying out the irradiations, the phantom was 
aligned with the beam such that the width and depth of the BP were in the phantom. This was 
achieved using a large diameter multi layer ionization chamber, Giraffe (IBA Dosimetry), 
which allowed us to confirm the WET of our setup.
A beam energy of 226 MeV was used and each depth was irradiated with 20 MU corresp-
onding to a dose range of 6–37 cGy. Gafchromic films were calibrated covering a range from 
0–250 cGy, using a clinically used procedure (Reinhardt et  al 2012). In summary an ion 
Figure 2. (A) Custom made film phantom able to take measurements 1 mm apart. (B) 
Setup used for the experiment in Trento comprised of solid water slabs, used to provide 
sufficient buildup before the film phantom. The water equivalent thickness (WET) of 
the slabs was 29.1 cm allowing the width of the BP to fall within the film phantom.
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chamber was used to determine the dose delivered to the film, where a calibration curve was 
produced to convert values of Gafchromic film optical density to known dose. Reference 
water measurements were carried out initially using Gafchromic films at depths of 0 and 
17 cm outside the film phantom and nine measurements in the phantom between 30.3 and 
33.2 cm, corresponding to a net peak water dose of 37 cGy, such that a depth dose plot could 
be obtained. After irradiation each film was contained in a light-tight envelope and kept at 
room temperature. The film phantom was filled with the two nanoparticle concentrations and 
irradiated. After 24 h the results were read out using an EPSON desktop scanner, where the 
pixel values from the red channel and optical density was determined for each measured point. 
With the depth dose plot, it was possible to determine the DEF for each concentration. The 
plot was also used to calculate the expected shift of the distal edge, where as before, the end 
of range was used comparing water  +  gold nanoparticles to water alone.
3. Results
3.1. Effect on the distribution of energy deposition
Nano-films demonstrated the effects on energy distribution in the longitudinal beam direction, 
where it was shown that high concentrations caused changes to Bragg peak shape through 
both a shift in the distal edge and a narrowing of the overall BP width. Depth dose plots were 
used to show the effect of nano-films on energy deposition.
3.1.1. Simulated longitudinal shift and BP width narrowing. High concentrations resulted in 
significant changes to the shape of the BP (figure 3).
The longitudinal shift for both energies are presented in table  1. The highest shift was 
found to be 5.3 mm with Pt at 226 MeV with a concentration of 6.5 mg ml−1.
The BP width had been narrowed due to the nano-films. As narrowing causes changes to 
the shape of the BP, measurements were carried out at two different points. As before, this 
increased with material density and concentration, where the results have been summarised 
in table 2. The greatest level of narrowing can be seen for the 80%–10% BP dose line at 
226 MeV, where Pt with a concentration of 6.5 mg ml−1 shows a narrowing of approximately 
40%. Similarly, for the 80%–80% BP dose line  at 60 MeV, Pt also showed the greatest change 
with 6.5 mg ml−1, where a narrowing of approximately 39% was observed.
3.1.2. Experimental validation of gold nanoparticle narrowing effects. Figure 4 demonstrates 
the experimental results of the phantom study, where a 14% narrowing was measured 
(80–10%), along with a 2.2 mm shift at a concentration of 5.5 mg ml−1. This effect was found 
to be concentration dependent, as no narrowing was observed with 1.1 mg ml−1. These two 
concentrations were also simulated, where the results in figure 4 show a BP shape change with 
a shift of 4.5 mm and narrowing of approximately 32% (80–10%) for 5.5 mg ml−1.
3.1.3. Simulated dose enhancement factor (DEF). Table 3 summarises the simulated DEF 
findings, where as expected there was an increase in enhancement with an increase in nano-
film concentration and material density. Pt having the highest density, showed DEFs of 1.069 
(6.9%) and 1.060 (6%) at 6.5 mg ml−1 for 60 and 226 MeV respectively. The difference in 
DEF between Pt and the other materials for this concentration was less than 2%.
3.1.4. Simulated enhancement range. Table 4 demonstrates the enhancement range for the 
DEF from simulation. It was found that Ag had the highest enhancement range for 60 MeV 
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with 0.58 mm at a concentration of 0.01 mg ml−1, compared to 0.46 mm at 6.5 mg ml−1. At 
226 MeV both Au and Pt offered the highest enhancement range with 5.6 mm at 0.01 mg 
ml−1, compared to 6.5 mg ml−1 where Au and Pt were 4.1 mm and 4.0 mm respectively. The 
main benefit of this measure was to show that although higher concentrations offer a higher 
enhancement in terms of peak dose value, the range in which they enhance the dose is reduced 
due to prematurely attenuating the beam. High-Z materials scatter protons through larger 
angles where an increase in the level of scatter is observed with decreasing concentration due 
Figure 3. Plots shown of simulated nano-film results, with nano-film regions beginning 
at depths of 31.31 and 3.02 cm for 226 and 60 MeV, respectively. All materials 
normalised to the peak water dose, demonstrating the level of enhancement and changes 
to the BP at 226 MeV for concentrations of (a) 6.5 mg ml−1 (b) 0.1 mg ml−1 and (c) 
0.01 mg ml−1 and 60 MeV for (d) 6.5 mg ml−1 (e) 0.1 mg ml−1 and (f) 0.01 mg ml−1.
Table 1. Longitudinal shift in the BP for all materials and all concentrations for an 
energy of 60 and 226 MeV.
Material
Longitudinal shift in the BP (mm)
6.5 mg ml−1 0.1 mg ml−1 0.01 mg ml−1
60 MeV 226 MeV 60 MeV 226 MeV 60 MeV 226 MeV
Ag 0.34  ±  0.01 3.7  ±  0.1 0.09  ±  0.01 0.9  ±  0.1 0.04  ±  0.01 0.5  ±  0.1
Au 0.40  ±  0.01 4.7  ±  0.1 0.11  ±  0.01 1.3  ±  0.1 0.05  ±  0.01 0.6  ±  0.1
Pt 0.43  ±  0.01 5.3  ±  0.1 0.12  ±  0.01 1.4  ±  0.1 0.06  ±  0.01 0.7  ±  0.1
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to the larger spacing between subsequent nano-films at low concentrations. As the concentra-
tion increases the range over which enhancement occurs is reduced. This is due to the fact 
that the incident beam has been attenuated by a greater amount of material with the higher 
concentrations and materials of a higher density.
3.2. Causes of dose enhancement
It is commonly understood within the literature that the main factor causing nanoparticle- 
induced dose enhancement is the resulting increase in number of secondary electrons (Regulla 
et al 1998, Kwon et al 2015). Our model corroborates with this as shown in figure 5, where an 
increase in the number of secondary electrons could be observed with an increase in nano-film 
concentration for both energies.
4. Discussion
The introduction of high-Z nano materials has been shown to cause a number of changes to the 
Bragg peak when introduced in proton therapy. The first of these is an increase in the level of 
Figure 4. (A) The dose enhancement from both Gafchromic film dose measurement 
in water and a water–gold nanoparticle solution at concentrations of 5.5 and 1.1 mgAu 
ml−1 and simulated results for these concentrations. (B) Depth dose plot showing the 
changes to the shape of the BP by normalising each to the respective peak dose.
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dose deposition, demonstrated by the DEF. Pt offered the greatest enhancement at the highest 
tested nano-film concentration of 6.5 mg ml−1 with simulated DEF of 1.069 and 1.060 at 60 
and 226 MeV respectively. As expected the level of enhancement increased with concentra-
tion, where three orders of magnitude of concentrations were presented. The increase from the 
lowest to highest concentration for Pt was approximately 6% for 60 MeV and 5% for 226 MeV. 
The range of enhancement however decreased with increasing concentration, where at 
60 MeV (226 MeV) the range for Pt reduced by 15% (29%) from 6.5 mg ml−1 to 0.01 mg ml−1. 
From the phantom experiment a DEF of approximately 1.26 was observed with a concen-
tration of 1.1 mg Au ml−1 and 1.21 with 5.5 mg Au ml−1. This was in disagreement with 
simulations which showed an increased DEF with concentration; however, it is thought that 
Gafchromic films were prone to quenching effects which may lead to lower observed DEF at 
higher concentrations. The DEF observed experimentally was greater than simulation; experi-
ment showed a DEF of 1.21 for gold nanoparticles at 5.5 mg ml−1, compared to the simulated 
DEF of 1.039 for the same concentration.
Importantly, both simulation and measurement found a narrowing of the BP width for 
nanoparticle  +  water compared to water alone. Simulations showed a narrowing of 23% from 
the 80%–80% BP dose line and 32% from the 80%–10% BP dose line at 226 MeV with Au at 
a concentration of 5.5 mg ml−1. Experimental findings demonstrated a narrowing of approxi-
mately 7% (80%–80%) and 14% (80%–10%) at gold nanoparticle concentration 5.5 mg ml−1 
and no observable narrowing at 1.1 mg ml−1. It is clinically known that high-Z materials cause 
a level of broadening in the beam, when introduced before the patient. Here however the high-
Z materials were located within the width of the BP, towards the end of range, causing a reduc-
tion in the level of range straggling and narrowing of the BP width. This resembles the clinical 
use of nanoparticles in proton beam therapy, where nanoparticles would be expected to fall 
within the BP width, being targeted and localised within the tumour. As incident protons 
have a finite amount of energy, their interactions with high-Z materials cause a reduction in 
Table 4. Enhancement range for all materials and all concentrations for energies of 60 
and 226 MeV.
Material
Enhancement range (mm)
0.01 mg ml−1 0.1 mg ml−1 6.5 mg ml−1
60 MeV 226 MeV 60 MeV 226 MeV 60 MeV 226 MeV
Ag 0.58 5.2 0.50 5.6 0.46 4.1
Au 0.57 5.6 0.51 5.1 0.45 4.1
Pt 0.52 5.6 0.54 5.1 0.44 4.0
Figure 5. Plot showing the increase in number of secondary electrons with increasing 
concentration for all materials with (a) 60 MeV beam and (b) 226 MeV.
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the range straggling normally observed with water, where protons reached their end of range 
closer together due to the barrier caused by the high-Z material. The BP changes were energy 
dependent; for high energy simulations the effects were more significant due to increased 
proto n range at high energies, where those with longer ranges have more measurable effects. 
It can be seen that this effect still occurred at the lower energy of 60 MeV. Differences between 
simulated and measured results were expected due to different set-ups, where simulations 
did not take beam divergence into account. Another reason for the expected differences was 
that experimentally the interactions that occur on the nanoscale differ greatly to what can be 
predicted on the macroscale. Further advancements in Monte Carlo physics lists are needed, 
for a variety of materials at the nanoscale, in order to improve the accuracy. Importantly, the 
use of nano-films to simulate nanoparticles within the model innately overestimated the level 
of change to the BP; in practice nanoparticles would be dispersed in all directions, and the 
incident proton would not necessarily encounter neighbouring nanoparticles at the frequency 
of consecutive nano-films. Both BP width narrowing and distal edge shift were overestimated 
in the simulation, where narrowing was 39% and shift was 51% lower experimentally.
Both simulations and experiment demonstrated a shift in the distal edge. It was found from 
the simulations that although Pt did not have the highest Z of the materials tested, it had the 
highest physical density, causing the highest level of change; a 5 mm shift in the distal edge 
compared to water alone was shown for Pt of concentration 6.5 mg ml−1 at 226 MeV. At the 
same energy, experimental findings demonstrated a 2.2 mm shift in the distal edge for Au at a 
concentration of 5.5 mg ml−1. This shift was expected and is observed clinically, where high 
density materials are known to cause a range shift in proton beam therapy (Nichiporov et al 
2011).
In terms of the causes of dose enhancement, the percentage increase in number of second-
ary electrons with nano-films  +  water compared with water alone was found to be greater at 
60 MeV than 226 MeV with an increase of 41% (3%) for Au at concentration 6.5 mg ml−1 at 
60 MeV (226 MeV). This is in agreement with the findings of Gao and Zheng (2014) which 
showed a higher number of secondary electrons produced at lower proton beam energies after 
interactions with gold nanoparticles. This may seem to contradict previous results where a 
greater shift was observed at higher energies, however the number of secondary electrons for 
226 MeV were three orders of magnitude higher than at 60 MeV.
With the level of dose enhancement demonstrated experimentally, it would be beneficial 
to use gold nanoparticles clinically to increase the level of dose deposition to the tumour. It 
should also be noted that enhancements presented here demonstrate physical dose enhance-
ment. As demonstrated by other groups with simulated MV photon studies, there is little or 
no physical dose enhancement predicted for these energies. Experimentally, cellular studies 
show significant cell kill enhancement and as such biological factors must also be accounted 
for (Jones et al 2010, Lechtman et al 2011, Butterworth et al 2012).
In terms of the concentrations considered, they are achievable in practice as demonstrated 
by Hainfeld et al (2004). This study quantified in vivo gold nanoparticle uptake levels, where 
an uptake concentration of 6.5 mg Au g−1 gold nanoparticles was shown in mice through a 
single intravenous injection. Just as importantly, a 90% lower concentration was achieved in 
healthy surrounding tissue. Therefore, the findings presented have the potential to be observed 
clinically. As such if nanoparticles are used clinically and this localisation is achieved, treat-
ment plans would then need to take these changes in account to ensure an accurate plan. 
Shifts in the sharp distal edge of the BP have potential to under-dose or miss irradiation of 
the tumour target (Paganetti 2012). With the introduction of nanoparticles, the cumulative 
effect on the uncertainties have not been previously evaluated. This study demonstrated exper-
imentally a significant change where in the case of a high gold nanoparticle concentration, 
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a 2.2 mm shift at the end of range should be taken into account. Therefore, with protons, great 
care must be taken when recommending the use of nanoparticles as the bulk effects on dose 
distribution must be fully understood, and changes to the BP should be accurately quantified 
such that treatment plans remain valid. In order to conclude on consequences of changes to the 
BP, a further study has been proposed, which will incorporate the use of a commercial treat-
ment planning system along with Monte Carlo simulations in order to obtain adequate dose 
distribution calculations.
5. Conclusions
This study demonstrates a flexible working model able to simulate concentrations represen-
tative of clinically achievable nanoparticle concentrations, in a non-computationally expen-
sive setup. Compared to other models which consider a single nanoparticle, this model was 
able to highlight the macro scale effects and investigate changes to the Bragg peak, whilst 
varying energy, and nanoparticle material and concentration. Both simulation and experiment 
demonstrated a change in the Bragg peak shape, where a shift of 4.5 mm was simulated for 
gold with 5.5 mg ml−1 compared to 2.2 mm measured experimentally. Differences in simula-
tion to experiment were due to differences in the distribution of gold nanoparticles in solu-
tion, as well as what practically occurs at the nanoscale compared to what is predicted on 
the macroscale. The width of the Bragg peak was shown to narrow in the simulations by 
approximately 23% compared to 14% from the experiment. Both demonstrated a level of 
dose enhancement, where experimental findings showed a higher level of 21% compared to 
simulated 4%. The simulations demonstrated concentration dependent longitudinal shifts in 
the Bragg peak, which were more evident at higher beam energies due to the longer proton 
range. At a concentration of 6.5 mg ml−1 platinum shifted by 5.3 mm at 226 MeV, compared 
to 0.43 mm at 60 MeV. These changes were also material dependent, where platinum caused 
the highest changes, followed by gold then silver, suggesting the effects were dependent on 
the physical density rather than the atomic number. In terms of the enhancement, simulations 
showed it to be concentration, material and energy dependent. Overall these results demon-
strate the need for quantifying the range of protons in a water to water-nanoparticle setup if 
nanoparticles are to be used for clinical proton treatments.
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